Goertz, Lukas http://orcid.org/0000-0002-2620-7611
Liebig, Thomas
Siebert, Eberhard
Zopfs, David
Pennig, Lenhard
Schlamann, Marc
Radomi, Alexandra
Dorn, Franziska
Kabbasch, Christoph
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 5 March 2024
Accepted: 22 May 2024
First Online: 19 June 2024
Declarations
:
: CK serves as consultant for Acandis GmbH (Pforzheim, Germany) and as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA). TL serves or previously served as proctor for MicroVention Inc./Sequent Medical, CERUS Endovascular (Fremont, CA, USA), Phenox (Bochum, Germany), Stryker (Kalamazoo, MI, USA), and Medtronic (Dublin, Ireland). FD serves as consultant/ proctor for MicroVention Inc./Sequent Medical, Balt (Irvine, CA, USA), Cerenovus/Johnson&Johnson (Irvine, CA, USA); received speakers honoraria from Cerenovus/ Johnson&Johnson, Acandis, Asahi (Tokyo, Japan), Q’Apel (Fremont, CA, USA), Penumbra (Alameda, CA, USA), Medtronic, Stryker; received scientific grants from Cerenovus/ Johnson&Johnson. DZ is on the speaker’s bureau of Philips (Amsterdam, the Netherlands) and lecturer for Amboss GmbH (Cologne, Germany). The other authors declare that they have no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case. For images or other information within the manuscript which identify patients, consent was obtained from them and/or their legal guardians.